Cystadane (Rare Disease Therapeutics, Inc.)
Welcome to the PulseAid listing for the Cystadane drug offered from Rare Disease Therapeutics, Inc.. This Methylating Activity [MoA],Methylating Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Rare Disease Therapeutics, Inc. |
| NON-PROPRIETARY NAME: | betaine |
| SUBSTANCE NAME: | BETAINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Methylating Activity [MoA],Methylating Agent [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | POWDER, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1996-10-25 |
| END MARKETING DATE: | 0000-00-00 |
Cystadane HUMAN PRESCRIPTION DRUG Details:
| Item Description | Cystadane from Rare Disease Therapeutics, Inc. |
| LABELER NAME: | Rare Disease Therapeutics, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 6(g/1) |
| START MARKETING DATE: | 1996-10-25 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 66621-4000_d797121e-e13a-41b8-b7d7-e104ba26077c |
| PRODUCT NDC: | 66621-4000 |
| APPLICATION NUMBER: | NDA020576 |
Other BETAINE Pharmaceutical Manufacturers / Labelers:
